These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6243359)

  • 1. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction.
    Simpson LL
    J Pharmacol Exp Ther; 1980 Jan; 212(1):16-21. PubMed ID: 6243359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular activity of BaTX, a presynaptic basic PLA2 isolated from Bothrops alternatus snake venom.
    Ponce-Soto LA; Barros JC; Marangoni S; Hernandez S; Dal Belo CA; Corrado AP; Hyslop S; Rodrigues-Simioni L
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):291-7. PubMed ID: 19463969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N; Kamata Y; Simpson LL
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic experiments on the interaction between crotoxin and the mammalian neuromuscular junction.
    Trivedi S; Kaiser II; Tanaka M; Simpson LL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):490-6. PubMed ID: 2553923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of acute and chronic botulinum toxin treatment on receptor number, receptor distribution and tissue sensitivity in rat diaphragm.
    Simpson LL
    J Pharmacol Exp Ther; 1977 Feb; 200(2):343-51. PubMed ID: 839441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
    Coffield JA; Bakry NM; Maksymowych AB; Simpson LL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of H2 receptor antagonists on neuromuscular transmission.
    Bossa R; Chiericozzi M; Efstathiu G; Galatulas I; Ninci MA
    In Vivo; 1991; 5(1):57-9. PubMed ID: 1681958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of botulinum toxin paralysis by low temperature.
    Lundh H
    Muscle Nerve; 1983 Jan; 6(1):56-60. PubMed ID: 6302501
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the presynaptic actions of botulinum toxin and beta-bungarotoxin on neuromuscular transmission.
    Chang CC; Huang MC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):129-42. PubMed ID: 4368526
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological studies on the subcellular site of action of botulinum toxin type A.
    Simpson LL
    J Pharmacol Exp Ther; 1978 Sep; 206(3):661-9. PubMed ID: 212546
    [No Abstract]   [Full Text] [Related]  

  • 13. [Paralysis of the anterior tibial muscle of the rat by the central action of botulinum toxin].
    Silva AJ
    Arch Farmacol Toxicol; 1979 Dec; 5(3):180-2. PubMed ID: 232648
    [No Abstract]   [Full Text] [Related]  

  • 14. The interaction between aminoquinolines and presynaptically acting neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):43-8. PubMed ID: 6283072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural probes for cholinergic sites: L-bebeerine actions on the neuromuscular transmission, the nicotinic receptor/ionic channel complex, and contraction of skeletal muscles.
    Souccar C; Borrás MR; Corrado AP; Lima-Landman MT; Lapa AJ
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):268-78. PubMed ID: 10797870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction.
    Sellin LC; Kauffman JA; Dasgupta BR
    Med Biol; 1983 Apr; 61(2):120-5. PubMed ID: 6308364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mode of action and effects of botulinum neurotoxin A].
    Périé S; Lacau St-Guily J
    Ann Otolaryngol Chir Cervicofac; 1996; 113(2):73-8. PubMed ID: 8999747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    Simpson LL; Coffield JA; Bakry N
    J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic requirements for the neuromuscular blocking action of botulinum toxin: implications with regard to synaptic transmission.
    Simpson LL
    Neuropharmacology; 1971 Nov; 10(6):673-84. PubMed ID: 4331443
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction between divalent cations and botulinum toxin type A in the paralysis of the rat phrenic nerve-hemidiaphragm preparation.
    Simpson LL
    Neuropharmacology; 1973 Feb; 12(2):165-76. PubMed ID: 4362622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.